0.8166  0.198 (32.07%)		11-02 16:00
Open: 0.6611 High: 0.87 Volume: 1,565,787		Pre. Close: 0.6183 Low: 0.6611 Market Cap: 15(M)

Short term
Mid term
Targets	6-month :	1.01	1-year :	1.18
Resists	First :	0.87	Second :	1.01
Pivot price	0.65
Supports	First :	0.69	Second :	0.58
MAs	MA(5) :	0.65	MA(20) :	0.68
	MA(100) :	1.16	MA(250) :	1.17
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	41.2	D(3) :	23.9
RSI	RSI(14): 62.3
52-week	High :	2.61	Low :	0.55

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ GNTA ] has closed Bollinger Bands are 53.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 24 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	0.64 - 0.64	0.64 - 0.64
Low:	0.59 - 0.59	0.59 - 0.6
Close:	0.61 - 0.62	0.62 - 0.62

Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors. Its activities and acquisition strategy covers aerospace, defense, national security, and biotechnology/biosecurity. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.

Mon, 02 Nov 2026
Genenta Science rebrands as Saentra Forge, shif... - Pluang

Mon, 02 Nov 2026
A new business name, not a legal-name change: Genenta Science (Nasdaq: GNTA) will use Saentra Forge. - Stock Titan

Mon, 02 Nov 2026
Genenta Unveils Saentra Forge as Its New Brand, Advancing Its Transformation into a Strategic Industrial Platform - The Manila Times

Mon, 02 Nov 2026
Genenta Science rebrands as Saentra Forge, changes ticker to SAEN - StreetInsider

Mon, 02 Nov 2026
Shareholders need no action as Genenta adopts the Saentra Forge name - Stock Titan

Sat, 24 Oct 2026
Genenta Science S.p.A. Estimates – NASDAQ:GNTA - TradingView

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Industrials
Industry: Aerospace & Defense
Shares Out	48 (M)
Shares Float	19 (M)
Held by Insiders	43.3 (%)
Held by Institutions	4.9 (%)
Shares Short	110 (K)
Shares Short P.Month	126 (K)

EPS	-0.38
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	1.04
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-17.7 %
Return on Equity (ttm)	-38.1 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	-0.14
Qtrly Earnings Growth	0 %
Operating Cash Flow	-7 (M)
Levered Free Cash Flow	-3 (M)

PE Ratio	-2.24
PEG Ratio	0
Price to Book value	0.78
Price to Sales	0
Price to Cash Flow	-5.8

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.